Durable response to CAR T is associated with elevated activation and clonotypic expansion of the cytotoxic native T cell repertoire
Giulia Cheloni(Tumour Institute of Tuscany), David Avigan(Beth Israel Deaconess Medical Center), Mike Mattie, Eleni Kanata(Broad Institute), Gayatri Tiwari, Ioannis S. Vlachos(Broad Institute), Kathrine S Rallis(Beth Israel Deaconess Medical Center), Jacalyn Rosenblatt(Beth Israel Deaconess Medical Center), Jenny Kim, Yered Pita-Juárez(Broad Institute), Georges Chedid(Beth Israel Deaconess Medical Center), Zachary M. Avigan(Icahn School of Medicine at Mount Sinai), Isabella Saldarriaga(Beth Israel Deaconess Medical Center), Daniela Torres(Beth Israel Deaconess Medical Center), Brodie Miles(Children's Cancer Therapy Development Institute), Jessica Liegel(Beth Israel Deaconess Medical Center), Dimitra Karagkouni(University of Thessaly)
Cited by 18
Related Papers
DIANA-miRPath v3.0: deciphering microRNA function with experimental support
|Nucleic Acids Research|2015|1.8k
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2019|1.7k
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
|Science|2019|1.4k
DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions
|Nucleic Acids Research|2017|1.2k
DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows
|Nucleic Acids Research|2013|1.2k